The biotechs promising to slow down aging

Unity Biotechnology is a biotech based in San Francisco, California, listed in May (Nasdaq), with the ambitious objective to develop treatments slowing down ageing and increasing patients’ life expectancy.  Unity Biotechnology’s targets are ageing cells, also referred to as zombie cells: they can no longer reproduce and they release a protein that causes inflammation and damages to surrounding tissues. The discoveries of new procedures to attack and neutralize zombie cells have been reported in various articles published in the prestigious journal Nature over the last two years.